Brief: Theraclion enters commercial agreement with Tubingen University
19/04/2016 16:45
April 19 (Reuters) - Theraclion SA ALTHER.PA :
* Tubingen University publishes positive results on
echotherapy breast fibroadenoma clinical trial and enters a
commercial agreement with Theraclion
Source text for Eikon: ID:nBw4tv4lFa
Further company coverage: ALTHER.PA
(Gdynia Newsroom:)
((Gdynia.newsroom@thomsonreuters.com; +48 58 698 39 20;))
Recent news on Theraclion SA
See all newsBrief: Theraclion Appoints Claude Lenoir As Interim Chairman
Brief: Theraclion Secures U.S. Reimbursement Milestone for Sonovein With New Category III CPT Code
French and Benelux stocks-Factors to watch
Brief: Inner Mongolia Furui Medical Raises Stake In Theraclion
Brief: French medical technology company Theraclion strikes partnership with Chinese company Furui and names new CEO